Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoHis Last Day As A Teacher After 36 Years. They Turned It Into A Memory For Life

feel good storiesMailman Shares All The Adorable Snowmen Found On Her Route This Winter

feel good storiesMeet Despereaux, The Adorable Dumbo Mouse You’ll Want To See

feel good storiesKids Are Loving The Tiny Duck Libraries Popping Up Around New York City

feel good stories'I Laughed And Cried': Vet’s Hilarious Condolence Card Brings Laughter To Grieving Cat Owner

feel good storiesTeen Runs His Own Restaurant ALONE — One Of The Most Uplifting Stories You'll Read

feel good videoUnexpected Friends: Rhino And Tiny Deer Play In Snow

feel good videoSheep Escape Herd And Wander Into Supermarket In Funny Video

feel good videoDonkey Gets Tricked Into Taking His Medicine — And It’s Adorable

feel good videoKissing Rescue Dogs And Filming Their Reactions

feel good videoI Picked Up My Sister From Work At A Doggy Daycare — Then This Happened